• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
IMPL

IMPL

Impel Pharmaceuticals Inc.

NASDAQHealthcareBiotechnologyUS

USD0.04

-0.01 (-27.27%)

Company Profile

CEO

Leonard S. Paolillo

IPO Date

2021-04-23

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.04

Prev. Close

$0.06

Day Low

$0.02

Day High

$0.05

52W Low

$0.02

52W High

$4.20

Market Cap

$0.00B

Volume

0.72M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

4

Avg Positive

28.3%

Avg Negative

1.5%

Avg Neutral

70.0%

News Feed

Impel NeuroPharma Enters Into a $50 Million Debt Financing Agreement With Oxford Finance LLC and Silicon Valley Bank

GlobeNewsWire·7/7/2021·↑ positive

Impel NeuroPharma Announces First Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·6/7/2021·↑ positive

Impel Neuropharma raises $80M in Washington state's first IPO of 2021

GeekWire
·4/23/2021
·↑ positive

Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering

GlobeNewsWire·4/22/2021·↑ positive